oml banner
 Home Services Sample Submission Order Supplies Meet Our Team Science Contact Us TL VetPath
petri dishes

About Us

Welcome to the Ocular Microbiology Laboratory of the Animal Eye Consultants of Iowa. We are the very first veterinary service strictly focused on providing veterinary ocular microbiology services in the USA.

Why submit your cases to us?

  1. We use antibiotic susceptibility panels that are clinically relevant to the ophthalmic bacterial infections
  2. Bacterial growth from patient ocular samples in our laboratory is currently 74% which is substantially higher than reported in the veterinary and human ocular microbiology literature, due to the uniquely developed protocols in our laboratory
  3. We are strictly focused on ocular and periocular diseases, and we continuously collaborate with veterinary ophthalmology specialists to gain better understanding and significance of obtained microbiology results for the observed clinical condition

Antibiotic susceptibility panels are analyzed according to the latest Clinical and Laboratory Standards Institute (CLSI) guidelines.


Example of aggressive corneal infection resulting in the central degradation of the conjunctival pedicle graft 4 weeks after surgery by Staphylococcus pseudintermedius

aggressive corneal infection

Amoxicillin/Clavulanic acid - R
Amikacin - R
Bacitracin - S
Cefoxitin - R
Gentamicin - R
Neomycin - R
Ofloxacin - R
Polymixin - R
Tetracycline - R
Tobramycin - R
Vancomycin - I
Ciprofloxacin - R
Clindamycin - R

Doxycycline - R
Enrofloxacin - R
Cephalexin - R
Marbofloxacin - R
Penicillin - R
Sulfamethoxazole/Trimethoprim - R
PBP2A – positive


Why pursuing ocular microbiology sampling in patients with corneal ulcers?


Based on the analysis of microbiology isolates in our laboratory there is currently 40-84% chance that the use of single antibiotic for the treatment of canine stromal corneal ulcers will be effective, while combined use of two to four antibiotics may be effective in 57-99% of canine patients with corneal stromal ulcers.

Percentage of susceptible (S) bacterial isolates to a single and combination antibiotics.

ANTIBIOTICS
S% (n=167)
NeoPolyBac + Amikacin
99%
NeoPolyBac + Ofloxacin
99%
NeoPolyBac + Cefazolin
97%
NeoPolyBac
96%
Amikacin + Cefazolin
93%
NeoPoly + Cefazolin
91%
Gentamicin + Cefazolin
90%
NeoPoly + Ofloxacin
90%
NeoPoly + Amikacin
89%
NeoPoly + Amikacin
89%
Gentamicin + Ofloxacin
88%
Ofloxacin + Cefazolin
87%
Amikacin
84%
Gentamicin
79%
NeoPoly
79%
Ofloxacin
77%
Bacitracin
74%
Neomycin
71%
Tobramycin
68%
Tetracycline
62%
Amoxicillin/Clavulanic acid
57%
Cefazolin
54%
Cefoxitin
54%
Oxacillin
41%
Polymixin B
40%